Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.86
15.03.23
€16.09
15.03.24
-59.36%
16.03.24

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€5.16
15.03.23
€34.08
15.03.24
97.49%
16.03.24

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€5.16
15.03.23
€34.08
15.03.24
97.49%
16.03.24

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€36.37
13.03.23
-
13.03.24
-27.88%
14.03.24

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€131.50
13.03.23
-
13.04.23
15.59%
14.04.23

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€302.40
13.03.23
-
13.04.23
11.97%
14.04.23

Could be very worthwhile Investment >20% year
buy
XOMA Corp.

Start price
Target price
Perf. (%)
€19.20
13.03.23
€64.33
13.03.24
19.79%
14.03.24

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€219.90
13.03.23
€247.40
13.03.24
14.78%
14.03.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€307.70
13.03.23
€350.10
13.03.24
124.73%
14.03.24

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.33
13.03.23
€56.02
13.03.24
-56.77%
14.03.24

buy
Seagen Inc.

Start price
Target price
Perf. (%)
€188.46
13.03.23
-
13.03.24
11.64%
14.03.24

Concert Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.88
12.03.23
-
12.03.24
0.00%
13.03.24

buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€102.32
11.03.23
-
11.03.24
7.90%
12.03.24

Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.15
11.03.23
-
11.03.24
18.11%
12.03.24

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.42
11.03.23
-
11.03.24
-21.70%
12.03.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.50
11.03.23
-
11.03.24
-31.76%
12.03.24

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.70
11.03.23
-
11.03.24
2.80%
12.03.24

Invitae Corp

Start price
Target price
Perf. (%)
€1.30
11.03.23
€0.40
11.03.24
-93.65%
12.03.24

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.22
11.03.23
€4.60
11.03.24
18.48%
19.05.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.93
11.03.23
€0.30
11.03.24
-77.19%
08.07.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€140.00
10.03.23
-
10.03.24
17.21%
11.03.24

Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€20.20
10.03.23
-
10.03.24
38.61%
11.03.24

Brainstorm Cell

Start price
Target price
Perf. (%)
€1.53
10.03.23
-
10.03.24
-80.89%
11.03.24

Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.55
10.03.23
-
10.03.24
60.53%
11.03.24

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€18.87
10.03.23
-
10.03.24
-91.41%
11.03.24